George R J, Parker C W
Howard Hughes Medical Institute, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
J Cell Biochem. 1990 Feb;42(2):71-81. doi: 10.1002/jcb.240420203.
A preliminary characterization of the protein phosphotyrosine phosphatase (PTPase) activity in human peripheral blood lymphocytes (PBL) has been made using two tyrosine-containing peptides and the epidermal growth factor receptor from A-431 cells as substrates. High PTPase activity with a pH optimum near 7.4 was observed in both the membrane and the cytosolic fractions. At least three distinct fractions with PTPase activity were separated on DEAE cellulose columns, indicating that the enzyme is heterogeneous. Vanadate, molybdate, and salts of zinc, copper, and mercury were all effective enzyme inhibitors, although the inhibition was generally incomplete and showed some variation with the enzyme preparation. The difficulty in completely inhibiting PTPase activity in lymphocytes may help explain the variation between laboratories in studies of tyrosine phosphorylation in these cells. Studies with highly purified T lymphocytes obtained by filtration of PBL through nylon wool columns indicated that the activity is present in T cells. Absorption with agarose containing anti-HLe-1, a mouse monoclonal IgG1 antibody specific for the leukocyte-specific surface protein T-200 (CD45), removed up to 40% of the PTPase activity. Enzyme activity was recovered on the immunoadsorbent after extensive washing, confirming that the enzyme was being bound to the beads. Immunoabsorbents containing other mouse IgG1 antibodies failed to bind PTPase activity, indicating that the binding to beads with anti-HLe-1 antibody is specific. Further characterization of the CD45 and PTPase activities in lymphocytes may provide a better understanding of the role of protein tyrosine phosphorylation in the regulation of proliferation and differentiation in these cells.
利用两种含酪氨酸的肽以及来自A-431细胞的表皮生长因子受体作为底物,对人外周血淋巴细胞(PBL)中的蛋白酪氨酸磷酸酶(PTPase)活性进行了初步表征。在膜组分和胞质组分中均观察到高PTPase活性,其最适pH接近7.4。在DEAE纤维素柱上分离出至少三个具有PTPase活性的不同组分,表明该酶具有异质性。钒酸盐、钼酸盐以及锌、铜和汞的盐都是有效的酶抑制剂,尽管抑制作用通常不完全,并且随酶制剂有所变化。淋巴细胞中PTPase活性难以完全抑制,这可能有助于解释不同实验室在这些细胞酪氨酸磷酸化研究中的差异。通过尼龙毛柱过滤PBL获得的高度纯化T淋巴细胞的研究表明,该活性存在于T细胞中。用含有抗HLe-1(一种针对白细胞特异性表面蛋白T-200(CD45)的小鼠单克隆IgG1抗体)的琼脂糖进行吸附,可去除高达40%的PTPase活性。经过大量洗涤后,免疫吸附剂上恢复了酶活性,证实酶与珠子结合。含有其他小鼠IgG1抗体的免疫吸附剂未能结合PTPase活性,表明与抗HLe-1抗体结合珠子的过程具有特异性。进一步表征淋巴细胞中的CD45和PTPase活性,可能有助于更好地理解蛋白酪氨酸磷酸化在这些细胞增殖和分化调节中的作用。